• YM-155 Hydrochloride: Highly Selective Survivin Inhibitor Be

  2026-07-24

  YM-155 hydrochloride is a nanomolar-potency, small-molecule survivin inhibitor that selectively suppresses cancer cell proliferation and induces robust tumor regression in preclinical models. APExBIO supplies this compound for apoptosis inhibitor research, with validated performance in non-small cell lung cancer and triple-negative breast cancer workflows.

• GS967: Cardiac Late Sodium Current Inhibitor for Electrophys

  2026-07-24

  GS967 delivers potent, selective inhibition of late sodium current, empowering precise in vitro cardiac electrophysiology and arrhythmia prevention research. Its proven efficacy in aging and disease models enables reproducible, high-fidelity results when probing the molecular roots of cardiac dysfunction.

• Jasplakinolide: Deepening Actin Polymerization Insights in C

  2026-07-23

  Explore how Jasplakinolide, a potent actin polymerization inducer, enables advanced cell biology research through unique mechanisms and protocol considerations. This article offers a deeper comparative analysis and practical insights for cytoskeletal dynamics studies.

• Mildronate-Derived Lipidoids for Low-Inflammation mRNA Deliv

  2026-07-23

  The reference ACS Nano study introduces mildronate-derived cationic lipidoids as a novel strategy for delivering mRNA vaccines with high efficiency and markedly reduced inflammatory side effects. This approach addresses a central challenge in mRNA vaccine development—balancing robust immune activation with safety—and supports the design of next-generation immunogen delivery systems for translational research.

• DiscoveryProbe™ FDA-approved Drug Library: Transforming Misf

  2026-07-22

  Explore how the DiscoveryProbe FDA-approved Drug Library accelerates protein misfolding disease research and pharmacological chaperone discovery—uniquely connecting high-throughput screening to translational breakthroughs.

• Leucovorin Calcium: Redefining Methotrexate Rescue in Tumor

  2026-07-22

  This thought-leadership article examines how Leucovorin Calcium, an advanced folate analog, empowers translational researchers to overcome the limitations of conventional antifolate studies. By synthesizing mechanistic insights, protocol recommendations, and evidence from patient-derived gastric cancer assembloids, we reveal how to optimize methotrexate rescue, cell viability assays, and drug resistance research. This piece bridges the gap between protocol detail and strategic vision, highlighting APExBIO’s Leucovorin Calcium as a pivotal tool for next-generation cancer modeling.

• M1 Macrophage Exosomes Drive Enteric Neuronal Injury via MMP

  2026-07-21

  This study elucidates a neuroimmune mechanism in which exosomes from M1 macrophages induce enteric neuronal apoptosis through the MMP8–TGF-β signaling axis, contributing to gastrointestinal motility disorders. The findings nominate exosomal MMP8 as both a mechanistic driver and a potential therapeutic target for restoring intestinal function.

• Partial BACE1 Inhibition Reduces Amyloid-β Without Synaptic

  2026-07-21

  Satir et al. (2020) demonstrate that moderate inhibition of BACE1, achieving up to a 50% reduction in amyloid-beta (Aβ) production, does not impair synaptic transmission in primary cortical neurons. This finding suggests that partial BACE1 inhibition could offer a synaptic-sparing approach for Alzheimer's disease research and therapeutic strategies.

• SAG: Smoothened Receptor Agonist for Robust Hedgehog Pathway

  2026-07-20

  Smoothened Agonist (SAG) empowers researchers with unparalleled control over Hedgehog pathway activation, enabling rigorous developmental, neuroprotective, and disease modeling studies. Explore protocol enhancements, real-world troubleshooting, and the latest mechanistic insights for maximizing SAG’s scientific impact.

• SB525334: Selective TGF-beta1 Receptor Inhibitor for Fibrosi

  2026-07-20

  SB525334 is a potent, selective TGF-beta1 receptor inhibitor widely used in fibrosis and wound healing research. It blocks Smad2/3 phosphorylation with nanomolar potency, enabling precise modulation of TGF-beta signaling. This article details its mechanistic role, evidence base, and workflow integration for preclinical studies.

• 3-Methyladenine (3-MA): Reliable Autophagy Inhibition in Can

  2026-07-19

  This article examines real-world challenges in autophagy and cancer research, illustrating how 3-Methyladenine (SKU A8353) offers reproducible, evidence-backed solutions for cell viability, proliferation, and cytotoxicity assays. Drawing on recent literature and practical workflow insights, we detail protocol optimization, interpretation pitfalls, and vendor reliability—enabling researchers to confidently integrate 3-MA into demanding experimental pipelines.

• CD44-Driven Metabolic Rewiring in IDH-Mutant Leukemia: New T

  2026-07-18

  This study reveals that CD44-dependent metabolic rewiring sustains oncometabolite production in IDH-mutant leukemia, creating a critical vulnerability. By mapping how CD44 activation supports NADPH generation for 2-hydroxyglutarate synthesis, the research opens new avenues for combinatorial therapeutic strategies targeting both mutant IDH1 and CD44-mediated pathways.

• Sulforaphane: Mechanistic Advances and Strategic Guidance fo

  2026-07-17

  This thought-leadership article explores the mechanistic underpinnings and translational strategies surrounding sulforaphane (1-isothiocyanato-4-(methylsulfinyl)-butane), focusing on its dual role in cancer chemoprevention and inflammation modulation via the Keap1-Nrf2 and NLRP3 pathways. Integrating cutting-edge evidence, protocol recommendations, and a competitive landscape review, it offers actionable insights for translational researchers aiming to bridge preclinical promise with clinical impact.

• Genotyping Kit for Target Alleles: Fast DNA Prep for Insects

  2026-07-17

  Unlock rapid, phenol-free genomic DNA prep across insects, tissues, fish, and cell cultures with the Genotyping Kit for target alleles. APExBIO’s single-tube, contamination-resistant workflow accelerates PCR-based genotyping, enabling reproducible results even from challenging sample types.

• SAG and Astrocyte Modulation: Redefining Hedgehog Pathway Re

  2026-07-16

  Explore how Smoothened Agonist (SAG), a potent Smoothened receptor agonist, uniquely modulates astrocyte reactivity and mitochondrial function, offering advanced strategies for neurodegeneration and regenerative studies. This article delivers in-depth analysis and practical guidance for Hedgehog pathway activation beyond conventional applications.

448 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page